Yoshimasa Aso

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Psychometric Properties

Heart Rate Variability

Peripheral Nerve

Top Venues

International journal of molecular sciences

Postgraduate medicine

International journal of clinical practice

Journal of diabetes investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshimasa Aso, Toshie Iijima, Teruo Jojima, Masahiro Saito, Dai Tanuma, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Isao Usui
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes. Postgraduate medicine 136 (3) (2024)
Yoshimasa Aso, Toshie Iijima, Teruo Jojima, Masahiro Saito, Dai Tanuma, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Isao Usui
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes. Postgraduate medicine 136 (3) (2024)
Yoshimasa Aso, Toshie Iijima, Teruo Jojima, Masahiro Saito, Dai Tanuma, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Isao Usui
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes. Postgraduate medicine (2024)
Yoshimasa Aso, Toshie Iijima, Teruo Jojima, Masahiro Saito, Dai Tanuma, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Isao Usui
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes. Postgraduate medicine (2024)
Haruka Kishi, Isao Usui, Teruo Jojima, Shiho Fujisaka, Sho Wakamatsu, Yuiko Mizunuma-Inoue, Takafumi Niitani, Shintaro Sakurai, Toshie Iijima, Takuya Tomaru, Kazuyuki Tobe, Yoshimasa Aso
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. International journal of molecular sciences 23 (23) (2022)
Haruka Kishi, Isao Usui, Teruo Jojima, Shiho Fujisaka, Sho Wakamatsu, Yuiko Mizunuma-Inoue, Takafumi Niitani, Shintaro Sakurai, Toshie Iijima, Takuya Tomaru, Kazuyuki Tobe, Yoshimasa Aso
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. International journal of molecular sciences 23 (23) (2022)
Haruka Kishi, Isao Usui, Teruo Jojima, Shiho Fujisaka, Sho Wakamatsu, Yuiko Mizunuma-Inoue, Takafumi Niitani, Shintaro Sakurai, Toshie Iijima, Takuya Tomaru, Kazuyuki Tobe, Yoshimasa Aso
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. International journal of molecular sciences 23 (23) (2022)
Masato Kase, Toshie Iijima, Takafumi Niitani, Masaaki Sagara, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes. Diabetology international 14 (1) (2022)
Haruka Kishi, Isao Usui, Teruo Jojima, Shiho Fujisaka, Sho Wakamatsu, Yuiko Mizunuma-Inoue, Takafumi Niitani, Shintaro Sakurai, Toshie Iijima, Takuya Tomaru, Kazuyuki Tobe, Yoshimasa Aso
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. International journal of molecular sciences 23 (23) (2022)
Haruka Kishi, Isao Usui, Teruo Jojima, Shiho Fujisaka, Sho Wakamatsu, Yuiko Mizunuma-Inoue, Takafumi Niitani, Shintaro Sakurai, Toshie Iijima, Takuya Tomaru, Kazuyuki Tobe, Yoshimasa Aso
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. International journal of molecular sciences 23 (23) (2022)
Masato Kase, Toshie Iijima, Takafumi Niitani, Masaaki Sagara, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes. Diabetology international 14 (1) (2022)
Nanako Hirao, Toshie Iijima, Dai Tanuma, Eriko Ohira, Hidetaka Kurai, Toshimitsu Shinzawa, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso
Effects of treatment with methimazole on circulating CD4<sup>+</sup> and CD8<sup>+</sup> T cells positive for programed cell death protein-1 and on subsets of CD4<sup>+</sup> T cells in untreated hyperthyroid patients with Graves' disease. Clinical endocrinology 97 (6) (2022)
Ikuko Shibasaki, Toshiaki Nakajima, Taira Fukuda, Takaaki Hasegawa, Hironaga Ogawa, Go Tsuchiya, Yusuke Takei, Masahiro Tezuka, Takashi Kato, Yuta Kanazawa, Yasuyuki Kano, Toshiyuki Kuwata, Motoshi Ouchi, Shigeru Toyoda, Yoshimasa Aso, Hirotsugu Fukuda
Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors. Journal of clinical medicine 11 (15) (2022)
Yoshimasa Aso
Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post-hoc analysis. Journal of diabetes investigation 12 (8) (2021)
Yoshimasa Aso, Masaaki Sagara, Takafumi Niitani, Kanako Kato, Toshie Iijima, Takuya Tomaru, Teruo Jojima, Isao Usui
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 69 (7) (2021)
Yoshimasa Aso
Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches. Journal of diabetes investigation (2021)
Toshie Iijima, Soichiro Hosonuma, Hidetaka Kurai, Hayato Kajitani, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors. International journal of clinical practice 75 (11) (2021)
Yoshimasa Aso, Yoshihisa Takada, Ken Tomotsune, Yasuko Chiba, Mihoko Matsumura, Teruo Jojima, Minoru Sato, Nobuya Fujita, Hisamoto Kuroda, Shunichi Murano, Isao Usui
Comparison of insulin degludec (IDeg)/insulin Aspart (IAsp) co-formulation therapy twice-daily with free combination of GLP-1 receptor agonist liraglutide plus insulin degludec in Tochigi: IDEAL Trial. International journal of clinical practice 75 (4) (2020)
Teruo Jojima, Sho Wakamatsu, Masato Kase, Toshie Iijima, Yuko Maejima, Kenju Shimomura, Takahiko Kogai, Takuya Tomaru, Isao Usui, Yoshimasa Aso
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma. International journal of molecular sciences 20 (20) (2019)
Yoshimasa Aso, Kanako Kato, Shintaro Sakurai, Haruka Kishi, Masanori Shimizu, Teruo Jojima, Toshie Iijima, Yuko Maejima, Kenju Shimomura, Isao Usui
Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease. International journal of clinical practice 73 (5) (2019)
Masanori Shimizu, Kunihiro Suzuki, Kanako Kato, Teruo Jojima, Toshie Iijima, Toshimitsu Murohisa, Makoto Iijima, Hidehiro Takekawa, Isao Usui, Hideyuki Hiraishi, Yoshimasa Aso
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. Diabetes, obesity & metabolism 21 (2) (2018)